Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the ...
West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about ...
Zacks Investment Research on MSN
WST's Q4 earnings & sales beat, SmartDose sale by mid-2026, stock up
West Pharmaceutical Services, Inc. WST delivered adjusted fourth-quarter 2025 earnings per share (EPS) of $2.04, which moved ...
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $805 million. The company ...
Shares of West Pharmaceutical Services (WST) have gained 7.3% over the past four weeks to close the last trading session at $216.64, but there could still be a solid upside left in the stock if ...
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in West Pharmaceutical Services, Inc. (Symbol: WST), where a total of 1,862 contracts have traded ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results